Terms: = Leukemia AND ETNK1, ENSG00000139163, 55500, Q9HBU6, Nbla10396, EKI1, EKI AND Treatment
5 results:
1. Atypical CML: diagnosis and treatment.
Breccia M
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
[TBL] [Abstract] [Full Text] [Related]
2. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
[TBL] [Abstract] [Full Text] [Related]
3. etnk1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.
Fontana D; Mauri M; Renso R; Docci M; Crespiatico I; Røst LM; Jang M; Niro A; D'Aliberti D; Massimino L; Bertagna M; Zambrotta G; Bossi M; Citterio S; Crescenzi B; Fanelli F; Cassina V; Corti R; Salerno D; Nardo L; Chinello C; Mantegazza F; Mecucci C; Magni F; Cavaletti G; Bruheim P; Rea D; Larsen S; Gambacorti-Passerini C; Piazza R
Nat Commun; 2020 Nov; 11(1):5938. PubMed ID: 33230096
[TBL] [Abstract] [Full Text] [Related]
4. Atypical Chronic Myeloid leukemia: Where Are We Now?
Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
[TBL] [Abstract] [Full Text] [Related]
5. [The regulation of eki-785 to the growth of U937 cell line].
Yuan XF; Lu SH; Feng Y; Liu N; Song X; Lu M
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):810-4. PubMed ID: 17416000
[TBL] [Abstract] [Full Text] [Related]